白血病约占癌肿总发病率的5％左右,急性粒细胞性白血病(AML)则是临床常见的恶性肿瘤。现将我市人民医院自1990～1995年79例急性粒细胞性白血病采用HOAP方案诱导缓解化学治疗情况分析如下: 1 临床资料 79例病例皆采用FAB(法—美—英)协作组分类,其中未分化型(M_1)37例,部分分化型(M_2)42例,年龄3～68岁,男性41人,女性38人。 Leukemia accounts for about 5% of the total incidence of cancer, and acute myelogenous leukemia (AML) is a common clinical malignancy. The analysis of 79 patients with acute myelocytic leukemia induced by the HOAP protocol in our city’s People’s Hospital during the period from 1990 to 1995 is analyzed as follows: 1 The clinical data of 79 cases were all classified by the FAB (French-U.S.-British) collaboration group. Undifferentiated (M_1) 37 patients, partially differentiated (M_2) 42 patients, aged 3 to 68 years, 41 men and 38 women.